MabCure, Inc. (MBCI) ist ein börsennotiertes Unternehmen im Energie Sektor, tätig in der Solar Branche. Der Hauptsitz des Unternehmens ist in White Plains, NY, United States. Der aktuelle CEO ist Jehu Thomas Degerold Hand.
MBCI hat IPO-Datum 2007-12-05, 3 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $36.61K.
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
